Lakshmanan Krishnamurti
Chief, Pediatric Hematology and Oncology · Yale-New Haven Hospital
Credentials: · · · ·
History
- Present
Pediatric Hematology and Oncology Division · Yale-New Haven Hospital
- Present
- 1983–1986
Hematology and Medical Oncology
- 1980–1983
University of Bombay
- 1976–1980
Armed Forces Medical College
Research
Review · Nature Reviews Disease Primers · 2018 · 1,134 citations
Blood · 2017 · 375 citations
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease
New England Journal of Medicine · 2022 · 352 citations
- NB
33 papers

15 papers
- SS
13 papers

12 papers

12 papers
- AA
11 papers
- AH
10 papers

10 papers
Grants
- 2015–2023
National Heart, Lung, and Blood Institute · U01
Contact PI · $7.3M · Yale University
- 2019–2022
Qualification of a Multidimensional Electronic Pain Diary for Sickle Cell Disease
Food and Drug Administration · U01
Contact PI · $250K · Emory University
- 2019–2022
Sickle Cell Post Transplantation Long Term and Late Effects Registry ( STELLAR)
National Heart, Lung, and Blood Institute · OT2
Contact PI · $750K · Emory University
- 2011–2016
Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease
National Heart, Lung, and Blood Institute · R34
Contact PI · $734.3K · Emory University
Clinical trials
- 2019–2021
Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow
Principal investigator · Completed · Phase 2
Emory University
- 2018–2019
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
Principal investigator · Terminated
Emory University
- 2017–2018
Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease
Principal investigator · Withdrawn · Phase 1
Emory University
- 2017–2023
